New RNA-Based Tool Could Assess Preeclampsia Risk
New RNA-Based Tool Could Assess Preeclampsia Risk
Transcripts circulating in the blood provide real-time information about maternal, fetal, and placental health.
New RNA-Based Tool Could Assess Preeclampsia Risk
New RNA-Based Tool Could Assess Preeclampsia Risk

Transcripts circulating in the blood provide real-time information about maternal, fetal, and placental health.

Transcripts circulating in the blood provide real-time information about maternal, fetal, and placental health.

Illumina
Illumina to Buy Pacific Biosciences for $1.2 Billion
Illumina to Buy Pacific Biosciences for $1.2 Billion
Kerry Grens | Nov 6, 2018
The purchase adds long-read sequencing to Illumina’s portfolio.
Nanopore Sequencing Lawsuit
Nanopore Sequencing Lawsuit
Catherine Offord | Feb 29, 2016
Illumina accuses Oxford Nanopore Technologies of developing nanopore-based sequencing strategies covered by its patents.
Same Day Genomes
Megan Scudellari | Jan 13, 2012
Two new sequencing machines will read a human genome in 24 hours.